The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol
Citations
1,215 citations
996 citations
362 citations
Cites background or methods from "The treatment of super-refractory s..."
...viewed elsewhere (Shorvon and Ferlisi, 2011), and these findings...
[...]
...categorizing outcome Details of the literature used as the basis of this review are published elsewhere (Shorvon and Ferlisi, 2011, including the associated Supplementary material)....
[...]
...Their advantages and disadvantages have been reviewed elsewhere (Shorvon and Ferlisi, 2011), and these findings are summarized in Table 4....
[...]
...A number of therapies are in current usage and the literature reporting these therapies has been reviewed in detail elsewhere (Shorvon and Ferlisi, 2011)....
[...]
...A treatment protocol has been suggested elsewhere (Shorvon and Ferlisi, 2011)....
[...]
213 citations
191 citations
Cites background or methods from "The treatment of super-refractory s..."
...Of interest, the clinical protocol for the treatment of SRSE includes the use of intravenous steroids and IgG ‘‘for all patients in whom there is no cause identified for the super-refractory status epilepticus’’ (Shorvon & Ferlisi, 2011)....
[...]
...Recently, a role for BBB dysfunction in super refractory status epilepticus (SRSE) was proposed (Shorvon & Ferlisi, 2011)....
[...]
...A role for BBB dysfunction was also proposed for super refractory status epilepticus (Shorvon & Ferlisi, 2011)....
[...]
References
3,977 citations
"The treatment of super-refractory s..." refers background in this paper
...There is a body of experimental evidence demonstrating its anti-epileptic action (Nowak et al., 1984), and its effect in blockading the N-methyl-D-aspartate receptor may be the basis of this action....
[...]
786 citations
"The treatment of super-refractory s..." refers background in this paper
...…epileptogenesis, and especially the activation of specific inflammatory signalling pathways such as the interleukin-1 receptor/toll-like receptor (IL-1R/ TLR) pathway, both experimentally and in human tissue (Vezzani et al., 2009; Maroso et al., 2010; Vezzani and Ruegg, 2011; Zurolo et al., 2011)....
[...]
605 citations
"The treatment of super-refractory s..." refers background in this paper
...Other retrospective studies have shown that 12–43% of the cases with status epilepticus become refractory (Lowenstein and Aldredge, 1993; Mayer et al., 2002; Holtkamp et al., 2005; Rosetti et al., 2005)....
[...]
...BRAIN A JOURNAL OF NEUROLOGY...
[...]
509 citations